Harmony Biosciences Holdings, Inc. will showcase its commitment to innovation in healthcare by participating in a fireside chat at the 2025 Cantor Global Healthcare Conference in New York. This event is scheduled for September 4, 2025, at 2:10 p.m. ET. The conversation will feature insights from the company’s management team and will be accessible to a wider audience through a live webcast on the company’s investor relations page.
Founded in 2017 and headquartered in Plymouth Meeting, Pennsylvania, Harmony Biosciences focuses on developing therapies for patients suffering from rare neurological diseases and addressing unmet medical needs. The company is dedicated to enhancing the quality of life for individuals with these conditions and supporting the communities that often feel overlooked in the healthcare landscape.
The Cantor Global Healthcare Conference is a significant event that brings together industry leaders, investors, and stakeholders to discuss the latest advancements and challenges in the healthcare sector. Harmony’s participation highlights its ongoing efforts to connect with the investment community and share its vision for future developments.
For those interested in the latest updates from Harmony Biosciences and the broader landscape of healthcare innovations, the live discussion will also have an on-demand replay available after the event. This format ensures that stakeholders and interested parties can engage with the content at their convenience.
As Harmony Biosciences continues to advance its pipeline of treatments, its presence at such a prominent conference underscores its commitment to leading the charge in addressing critical health challenges faced by patients worldwide. The company’s ongoing mission is to develop effective therapies that not only meet medical needs but also uplift the quality of life for those in underserved communities.
For more information about the company and its activities, interested parties are encouraged to visit Harmony Biosciences’ investor relations page.